Your browser doesn't support javascript.
loading
Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies.
Xiang, Min Amy; Rybczynski, Philip J; Patel, Mona; Chen, Robert H; McComsey, David F; Zhang, Han-Cheng; Gunnet, Joseph W; Look, Richard; Wang, Yuanping; Minor, Lisa K; Zhong, H Marlon; Villani, Frank J; Demarest, Keith T; Damiano, Bruce P; Maryanoff, Bruce E.
Affiliation
  • Xiang MA; Research and Early Development, Johnson & Johnson Pharmaceutical Research & Development, 8 Clarke Drive, Cranbury, NJ 08512, USA.
Bioorg Med Chem Lett ; 17(23): 6623-8, 2007 Dec 01.
Article in En | MEDLINE | ID: mdl-17942308
Search on Google
Database: MEDLINE Main subject: Spiro Compounds / Benzazepines / Antidiuretic Hormone Receptor Antagonists Type of study: Diagnostic_studies Limits: Animals / Female / Humans / Male Language: En Year: 2007 Type: Article
Search on Google
Database: MEDLINE Main subject: Spiro Compounds / Benzazepines / Antidiuretic Hormone Receptor Antagonists Type of study: Diagnostic_studies Limits: Animals / Female / Humans / Male Language: En Year: 2007 Type: Article